drugset / Trial / NCT04670666
Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Madalena association in the treatment of type 2 diabetes mellitus.
Timeline
- Start
- 2024-11-18
- Primary completion
- 2026-07
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Empagliflozin | Small molecule | 10 mg | Oral |
| Comparator | Linagliptin | Small molecule | 5 mg | Oral |
| Subject | MADALENA ASSOCIATION | Unknown | — | Oral |
| Comparator | Metformin | Small molecule | 1000 mg | Oral |